Loading clinical trials...
Loading clinical trials...
Conditions
Locations
9
Austria
Landeskrankenhaus Feldkirch, Innere Med. II, Interne E
Feldkirch, Austria
Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken
Innsbruck, Austria
A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie
Kufstein, Austria
KUK Linz: Klinik für Interne 3 - Schwerpunkt Hämatologie und Onkologie
Linz, Austria
Ordensklinikum Linz GmbH - Barmherzige Schwestern; Interne I: Medizinische Onkologie und Hämatologie
Linz, Austria
Ordensklinikum Linz GmbH, Elisabethinen, I. Interne Abteilung Hämato-Onkologie
Linz, Austria
Start Date
March 24, 2022
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2027
Last Updated
April 10, 2025
NCT07277231
NCT05006716
NCT06859424
NCT01804686
NCT05254743
NCT05371808
Lead Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions